It is important to realize that physicians and scientists are no longer the only gatekeepers for individual genetic information. Direct-to-consumer companies offer genome-wide data and, in some cases, PRSs for multiple conditions, including psychiatric disorders. Individual patients may obtain this information and may bring it to their doctors. It is incumbent on clinical professionals to guide patients on conservative interpretation of such data.
